Related Experiment Video
Updated: Jul 27, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.2K
An Update on Familial Mediterranean Fever
Maddalena Lancieri1, Marta Bustaffa1, Serena Palmeri1
1UOC Malattie Autoinfiammatorie e Immunodeficenze, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
International Journal of Molecular Sciences
|June 10, 2023
Summary
Familial Mediterranean Fever (FMF) is an autoinflammatory disease causing recurrent inflammation. This review updates FMF pathophysiology, genetics, diagnosis, and treatment, including resistance and compliance.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Familial Mediterranean Fever (FMF) is the primary autoinflammatory disorder.
- Characterized by recurrent neutrophilic inflammation and polyserositis.
- Associated with severe complications like renal amyloidosis.
Purpose of the Study:
- To provide an updated overview of FMF.
- Integrate recent literature with novel insights on treatment resistance and compliance.
- Clarify pathophysiology, genetics, diagnosis, and treatment.
Main Methods:
- Literature review of recent studies on FMF.
- Integration of current data on treatment resistance and patient compliance.
- Synthesis of information on FMF pathophysiology, genetics, diagnosis, and treatment.
Main Results:
- FMF typically presents in childhood with fever and polyserositis.
- Long-term complications include renal amyloidosis.
- Recent characterization has improved understanding of FMF.
Conclusions:
- The review offers an updated perspective on FMF.
- Includes real-life outcomes of treatment resistance recommendations.
- Enhances understanding of autoinflammatory processes and innate immunity.
Keywords:
Familial Mediterranean FeverInterlukin-1 Inhibitorsautoinflammatory diseasechildrencolchicinecolchicine resistanceMore Related Videos
Related Concept Videos
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:17Pericarditis III: Medical Management
16
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
16
01:21Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
01:27Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
01:22Methods of reducing fever
707
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
707
01:21Myocarditis I: Introduction
10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10